471 El Camino Real Ste 101
Santa Clara, California 95050-4482
SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that certain CD Horizon Solera 5.5mm and 6.0mm posterior spinal fixation rods manufactured by Medtronic Sofamor Danek USA Inc., a division of Medtronic plc, meet SI-BONE’s criteria for compatibility with
SI-BONE, Inc. presents compelling long-term value with robust growth in unit economics, high gross profits, and attractive valuation upside. Read more on SIBN.
Morgan Stanley has added SI-Bone to its list of top medtech picks in the small-to-medium cap space, but downgraded Stevanato, Sight Sciences, Integra and Agiliti. Read more here.
SI-BONE, Inc. (NASDAQ:NASDAQ:SIBN) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ETCompany ParticipantsSaqib Iqbal - Senior Director, FP&A and Investor RelationsLaura Francis…
SI-BONE press release (SIBN): Q2 GAAP EPS of -$0.30 beats by $0.10.Revenue of $33.3M (+30.1% Y/Y) beats by $1.95M.Shares +4.48%.Based on the strength of performance in the…
SI-BONE (NASDAQ: SIBN ) is set to give its latest quarterly earnings report on Monday, 2023-08-07. Here''s what investors need to know before the announcement. Analysts estimate that SI-BONE will report an earnings per share (EPS) of $-0.41. SI-BONE bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com